The CDC recommends that all individuals aged 75 and older, as well as adults aged 60 and older who are at risk for severe RSV ...

Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

AUSTIN (KXAN) — In 2023, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

The Eastern Ontario Health Unit is advising a new treatment is now available in the region to help protect infants from the most-severe effects of respiratory syncytial virus (RSV).